EARLY ONSET ALZHEIMER DISEASE
Clinical trials for EARLY ONSET ALZHEIMER DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ONSET ALZHEIMER DISEASE trials appear
Sign up with your email to follow new studies for EARLY ONSET ALZHEIMER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New spinal injection drug enters first human test for early Alzheimer's
Disease control Recruiting nowThis early-stage study is testing the safety and effects of a new drug called ALN-APP for people with early-onset Alzheimer's disease. The drug is given as an injection into the spinal fluid. Researchers will monitor 60 participants to see how their bodies handle the drug and che…
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Phase: PHASE1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Mar 02, 2026 15:25 UTC
-
Scientists launch major study to map the journey of early Alzheimer's
Knowledge-focused Recruiting nowThis study aims to understand how early-onset Alzheimer's disease changes over time in people aged 40-64. Researchers will follow about 850 participants with and without memory problems for 2-4 years, using brain scans, memory tests, and fluid samples. The goal is to gather detai…
Matched conditions: EARLY ONSET ALZHEIMER DISEASE
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC